Correlation Between Genenta Science and EPIRUS Biopharmaceutica

Can any of the company-specific risk be diversified away by investing in both Genenta Science and EPIRUS Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genenta Science and EPIRUS Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genenta Science SpA and EPIRUS Biopharmaceuticals, you can compare the effects of market volatilities on Genenta Science and EPIRUS Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genenta Science with a short position of EPIRUS Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genenta Science and EPIRUS Biopharmaceutica.

Diversification Opportunities for Genenta Science and EPIRUS Biopharmaceutica

0.0

Correlation Coefficient

Genenta Science  EPIRUS Biopharmaceutica

Pay attention - limited upside

The 3 months correlation between Genenta and EPIRUS is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Genenta Science SpA and EPIRUS Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EPIRUS Biopharmaceuticals and Genenta Science is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genenta Science SpA are associated (or correlated) with EPIRUS Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EPIRUS Biopharmaceuticals has no effect on the direction of Genenta Science i.e., Genenta Science and EPIRUS Biopharmaceutica go up and down completely randomly.

Pair Corralation between Genenta Science and EPIRUS Biopharmaceutica

If you would invest (100.00) in EPIRUS Biopharmaceuticals on December 4, 2024 and sell it today you would earn a total of  100.00  from holding EPIRUS Biopharmaceuticals or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Genenta Science SpA  vs.  EPIRUS Biopharmaceuticals

Genenta Science SpA

Risk-Adjusted Performance

Very Weak

Over the last 90 days Genenta Science SpA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

EPIRUS Biopharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days EPIRUS Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, EPIRUS Biopharmaceutica is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Genenta Science and EPIRUS Biopharmaceutica

The main advantage of trading using opposite Genenta Science and EPIRUS Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genenta Science position performs unexpectedly, EPIRUS Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EPIRUS Biopharmaceutica will offset losses from the drop in EPIRUS Biopharmaceutica's long position.

The idea behind Genenta Science SpA and EPIRUS Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.